Analysis of the US and European Diabetes Diagnostics Market

Constricting Reimbursement Policies Restrain Market Growth

USD 6,950

* Required Fields

USD 6,950

PAY BY INVOICE

Be the first to review this product

The diabetes diagnostics markets in the United States and Europe have been in a mature stage for many years. Growth is sustained due to the high prevalence of diabetes in both regions. The segments covered in the study are self-monitoring of blood glucose (SMBG), point-of-care testing (POCT), and lab-based HbA1c testing. The emerging market of non-invasive technologies is disrupting this market space as it reduces patient pain points while providing accurate and sensitive results. Due to more hospital-centric care in the EU region, the POCT segment here experiences stronger growth than in the United States. POCT has the potential to grow the fastest due to its efficient, cost-effective solution and increasing adoption by physicians.

Table of Contents

1. Executive Summary
Key Findings
Scope and Segmentation
Market Engineering Measurements
CEO’s Perspective
Key Companies to Watch
HemoCue (US and Europe)
NovioSense (US)
Miraculins (US)
3 Big Predictions
2. Market Overview
Introduction to Diabetes
Market Overview
Market Segmentation
Segment Life Cycle Analysis
Competitive Segment Analysis
Defining Healthcare Trends in the Future
3. Competitive Playbook
Diabetes Diagnostics Market—Competitive Landscape
New Market Opportunities
Competitive Analysis
4. Total Market Analysis
Market Engineering Measurements
Revenue Forecast
Segment Overview
Revenue Forecast by Segment
5. US Analysis
Market Drivers
Switching to a value-based healthcare practice
Growing healthcare expenditure
Increasing push for decentralized testing
Growing trend of integrating technology with mobile devices
Increase in consumer-specific products
Market Restraints
Strained laboratory budgets
Competitive pricing
Tougher US regulatory environment
Market Engineering Measurements
US Revenue Forecast
Segment Overview
Revenue Forecast by Segment
6. US SMBG Segment
Market Engineering Measurements
Revenue Forecast
Revenue Forecast by Segment
Market Share Analysis
7. US POCT Segment
Market Engineering Measurements
Revenue Forecast
Revenue Forecast by Segment
Market Share Analysis
8. US Lab-based Testing Segment
Market Engineering Measurements
Revenue Forecast
Market Share Analysis
Lab-based Testing Trends
Comparison of Lab-based Tests
9. Europe Analysis
Market Engineering Measurements
Revenue Forecast
Revenue Forecast by Region
Segment Overview
10. Europe SMBG Segment
Market Engineering Measurements
Revenue Forecast
Revenue Forecast by Segment
Market Share Analysis
11. Europe POCT Segment
12. Europe Lab-based Testing Segment
Market Engineering Measurements
Revenue Forecast
Market Share Analysis
Lab-based Testing Trends
Comparison of Lab-based Tests
13. Europe—Regional Analysis
Regional Overview
Revenue Forecast—The United Kingdom
UK Regulations and Reimbursements
Revenue Forecast by Segment—The United Kingdom
Market Impact of Top 10 Trends
Revenue Forecast—Germany
Germany Reimbursements and Regulations
Revenue Forecast by Segment—Germany
Revenue Forecast—France
France Reimbursements and Regulations
Revenue Forecast by Segment—France
Revenue Forecast—Italy
Italy Reimbursements and Regulations
Revenue Forecast by Segment—Italy
Revenue Forecast—Spain
Spain Reimbursements and Regulations
Revenue Forecast by Segment—Spain
Revenue Forecast—Benelux (Belgium, the Netherlands, Luxembourg)
Benelux Reimbursements and Regulations
Revenue Forecast by Segment—Benelux
Revenue Forecast—Scandinavia
Scandinavia Reimbursements and Regulations
Revenue Forecast by Segment—Scandinavia
14. Key Companies to Watch
HemoCue
NovioSense
Miraculins
15. The Last Word
3 Big Predictions
16. Appendix
Market Engineering Methodology

Infographic



List of Figures & Charts

1. Total Diabetes Diagnostics Market: Competitive Segment Analysis, US and Europe, 2014
2. Total Diabetes Diagnostics Market: Market Outlook, US and Europe, 2014 and 2024
3. Total Diabetes Diagnostics Market: Game-changing Strategies, US and Europe, 2014
4. Total Diabetes Diagnostics Market: Top Product Analysis, US and Europe, 2014
5. Total Diabetes Diagnostics Market: Market Engineering Measurements, US and Europe, 2014
6. Diabetes Diagnostics Market: Key Market Drivers, US, 2015–2020
7. Diabetes Diagnostics Market: Key Market Restraints, US, 2015–2020
8. Diabetes Diagnostics Market: Market Engineering Measurements, US, 2014
9. SMBG Segment: Market Engineering Measurements, US, 2014
10. SMBG Segment: Market Positions of the Leading Participants, US, 2014
11. POCT Segment: Market Engineering Measurements, US, 2014
12. Lab-based HbA1c Testing Segment: Market Engineering Measurements, US, 2014
13. Diabetes Diagnostics Market: Market Engineering Measurements, Europe, 2014
14. SMBG Segment: Market Engineering Measurements, Europe, 2014
15. POCT Segment: Market Engineering Measurements, Europe, 2014
16. Lab-based HbA1c Testing Segment: Market Engineering Measurements, Europe, 2014


1. Total Diabetes Diagnostics Market: Market Engineering Measurements, US and Europe, 2014
2. Total Diabetes Diagnostics Market: Percent Prevalence of Diabetes, Global, 2014
3. Total Diabetes Diagnostics Market: Market Segmentation, US and Europe, 2014
4. Total Diabetes Diagnostics Market: Segment Life Cycle Analysis, US and Europe, 2014
5. Total Diabetes Diagnostics Market: Percent Revenue Breakdown, US and Europe, 2014
6. Total Diabetes Diagnostics Market: Competitive Landscape, US and Europe, 2014
7. Total Diabetes Diagnostics Market: Revenue Forecast, US and Europe, 2011–2020
8. Total Diabetes Diagnostics Market by Segment: Percent Sales Breakdown, US and Europe, 2014
9. Total Diabetes Diagnostics Market: Percent Sales Breakdown, US and Europe, 2020
10. Total Diabetes Diagnostics Market: Revenue Forecast by Segment, US and Europe, 2011–2020
11. Diabetes Diagnostics Market: Revenue Forecast, US, 2011–2020
12. Diabetes Diagnostics Market: Percent Sales Breakdown, US, 2014
13. Diabetes Diagnostics Market: Percent Sales Breakdown, US, 2020
14. Diabetes Diagnostics Market: Revenue Forecast by Segment, US, 2011–2020
15. SMBG Segment: Revenue Forecast, US, 2011–2020
16. SMBG Segment: Revenue Forecast by Sub-Segment, US, 2011–2020
17. SMBG Segment: Percent Revenue Breakdown, US, 2014
18. POCT Segment: Revenue Forecast, US, 2011–2020
19. POCT Segment: Revenue Forecast by Sub-Segment, US, 2011–2020
20. POCT Segment: Percent Revenue Breakdown, US, 2014
21. Lab-based HbA1c Testing Segment: Revenue Forecast, US, 2011–2020
22. Lab-based Testing Segment: Percent Revenue Breakdown, US, 2014
23. Diabetes Diagnostics Market: Trends of Lab-based Tests, US, 2014
24. FPG Testing: Market Potential, US, 2014
25. OGTT Testing: Market Potential, US, 2014
26. HbA1c Testing: Market Potential, US, 2014
27. Microalbumin: Market Potential, US, 2014
28. Diabetes Diagnostics Market: Revenue Forecast, Europe, 2011–2020
29. Diabetes Diagnostics Market: Revenue Forecast by Region, Europe, 2011–2020
30. Diabetes Diagnostics Market: Percent Sales Breakdown, Europe, 2014
31. Diabetes Diagnostics Market: Percent Sales Breakdown, Europe, 2020
32. SMBG Segment: Revenue Forecast, Europe, 2011–2020
33. SMBG Segment: Revenue Forecast by Segment, Europe, 2011–2020
34. SMBG Segment: Percent Revenue Breakdown, Europe, 2014
35. POCT Segment: Revenue Forecast, Europe, 2011–2020
36. POCT Segment: Revenue Forecast by Segment, Europe, 2011–2020
37. POCT Segment: Percent Revenue Breakdown, Europe, 2014
38. Lab-based HbA1c Testing Segment: Revenue Forecast, Europe, 2011–2020
39. Lab-based Testing Segment: Percent Revenue Breakdown, Europe, 2014
40. Diabetes Diagnostics Market: Trends of Lab-based Tests, Europe, 2014
41. FPG Testing: Market Potential, Europe, 2014
42. OGTT Testing: Market Potential, Europe, 2014
43. HbA1c Testing: Market Potential, Europe, 2014
44. Microalbumin: Market Potential, Europe, 2014
45. Diabetes Diagnostics Market: Percent Sales Breakdown by Region, Europe, 2014
46. Diabetes Diagnostics Market: Revenue Forecast, UK, 2011–2020
47. Diabetes Diagnostics Market: Demographic Information, UK, 2014
48. Diabetes Diagnostics Market: Revenue Forecast by Segment, UK, 2011–2020
49. Diabetes Diagnostics Market: Impact of Top 10 Trends, UK, 2014
50. Diabetes Diagnostics Market: Revenue Forecast, Germany, 2011–2020
51. Diabetes Diagnostics Market: Demographic Information, Germany, 2014
52. Diabetes Diagnostics Market: Revenue Forecast by Segment, Germany, 2011–2020
53. Diabetes Diagnostics Market: Impact of Top 10 Trends, Germany, 2014
54. Diabetes Diagnostics Market: Revenue Forecast, France, 2011–2020
55. Diabetes Diagnostics Market: Demographic Information, France, 2014
56. Diabetes Diagnostics Market: Revenue Forecast by Segment, France, 2011–2020
57. Diabetes Diagnostics Market: Impact of Top 10 Trends, France, 2014
58. Diabetes Diagnostics Market: Revenue Forecast, Italy, 2011–2020
59. Diabetes Diagnostics Market: Demographic Information, Italy, 2014
60. Diabetes Diagnostics Market: Revenue Forecast by Segment, Italy, 2011–2020
61. Diabetes Diagnostics Market: Impact of Top 10 Trends, Italy, 2014
62. Diabetes Diagnostics Market: Revenue Forecast, Spain, 2011–2020
63. Diabetes Diagnostics Market: Demographic Information, Spain, 2014
64. Diabetes Diagnostics Market: Revenue Forecast by Segment, Spain, 2011–2020
65. Diabetes Diagnostics Market: Impact of Top 10 Trends, Spain, 2014
66. Diabetes Diagnostics Market: Revenue Forecast, Benelux, 2011–2020
67. Diabetes Diagnostics Market: Demographic Information, Belgium, 2014
68. Diabetes Diagnostics Market: Demographic Information, the Netherlands, 2014
69. Diabetes Diagnostics Market: Revenue Forecast by Segment, Benelux, 2011–2020
70. Diabetes Diagnostics Market: Revenue Forecast, Scandinavia, 2011–2020
71. Diabetes Diagnostics Market: Demographic Information, Scandinavia, 2014
72. Diabetes Diagnostics Market: Revenue Forecast by Segment, Scandinavia, 2011–2020
73. Diabetes Diagnostics Market: Impact of Top 10 Trends, Benelux and Scandinavia, 2014



Keyword1

Keyword2

Keyword3

Related Research

Release Date : 07-Nov-17

Region : North America

Release Date : 31-Oct-17

Region : North America

Release Date : 17-Jul-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.